donepezil eg 5 mg film-coat. tabl.
eg sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil krka 5 mg film-coat. tabl.
krka d.d. novo mesto d.d. - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil sandoz 5 mg film-coat. tabl.
sandoz sa-nv - donepezil hydrochloride 5 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil sandoz 5 mg orodisp. tabl.
sandoz sa-nv - donepezil hydrochloride 5 mg - orodispersible tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil teva 5 mg orodisp. tabl.
teva pharma belgium sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - orodispersible tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil teva 5 mg film-coat. tabl.
teva pharma belgium sa-nv - donepezil hydrochloride 5 mg - eq. donepezil 4,56 mg - film-coated tablet - 5 mg - donepezil hydrochloride 5 mg - donepezil
donepezil hydrochloride- donepezil hydrochloride tablet
mckesson corporation dba sky packaging - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 5 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data ]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major
donepezil 5mg tablets
actavis uk ltd - donepezil hydrochloride - oral tablet - 5mg
donepezil hydrochloride tablet, film coated donepezil hydrochloride tablet, orally disintegrating
unichem pharmaceuticals (usa), inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride is indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major birth def
donepezil hydrochloride tablet, extended release
avkare - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 23 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer’s disease. donepezil hydrochloride tablets are contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. pregnancy category c: there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day (approximately 6 times the maximum recommended human dose [mrhd] of 23 mg/day on a mg/m 2 basis) and 10 mg/kg/day (approximately 7 times the mrhd on a mg/m 2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late g